Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Aktis Oncology Inc Com (AKTS)

113 + Investors. Track Smart Money conviction in AKTS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +46
Streak
1Q ▲
Buyers last Q
77%

Smart Money Signals — AKTS

Based on 113 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 1Q
For 1 consecutive quarter, more hedge funds added AKTS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
113 hedge funds hold AKTS right now — the highest count in 0.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🟢

More buyers than sellers — 77% buying

81 buying24 selling
Last quarter: 81 funds were net buyers (54 opened a brand new position + 27 added to an existing one). Only 24 were sellers (16 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.
🔄

Mostly new holders — 100% entered in last year

■ 0% conviction (2yr+) ■ 0% medium ■ 100% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Price up while funds trimmed (+82% value, -2% shares)

Value
+81%
Shares
-1%
Last quarter: total value of institutional AKTS holdings rose +82% even though funds reduced share count by 2%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new
Of 113 current holders: 113 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 22% AUM from major funds

22% from top-100 AUM funds
30 of 113 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.5
out of 10
Moderate Exit Risk
Exit risk score 5.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — AKTS

In 2026 Q2, 81 hedge funds were net buyers of AKTS (54 opened a new position, 27 added to an existing one), while 24 reduced or exited (16 trimmed, 8 sold completely) — a 77% buyer ratio, indicating clear institutional accumulation. 22% of total institutional value in AKTS is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +46 funds (more new holders than closures). Total institutional holders: 113.

Hedge Fund Ownership: AKTS

How many hedge funds hold AKTS — quarterly history vs. share price
Quarterly hedge fund ownership of AKTS vs. share price

Market Analysis: AKTS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: AKTS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 2 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
2.1
/ 10
conviction
Hedge Fund Positioning: AKTS
2026 Q3 Stats Unlock in 11 days 113 + Investors

Track Smart Money conviction in AKTS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 113 67 68.66%
13F Shares 34M 35M -1.59%
Total Value $1.01B $555M 81.86%
New Positions 54 67 -13
Increased Positions 27 0 +27
Closed Positions 8 0 +8
Reduced Positions 16 0 +16
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: AKTS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

113 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AKTS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 AKTS holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Blue Owl Capital Holdings LP 14.89% 3,070,219 $99.0M
2 MPM BioImpact LLC 9.50% 4,835,872 $155.9M
3 EcoR1 Capital, LLC 7.56% 4,824,469 $155.5M
4 Merck & Co., Inc. 5.83% 952,844 $30.7M
5 Octagon Capital Advisors LP 2.78% 960,847 $31.0M
6 Avidity Partners Management LP 2.50% 484,200 $15.6M
7 TCG Crossover Management, LLC 0.54% 696,560 $22.5M
8 Rtw Investments, LP 0.44% 1,592,043 $51.3M
9 Ra Capital Management, L.P. 0.37% 1,314,405 $42.4M
10 ArrowMark Colorado Holdings LLC 0.33% 245,872 $7.9M
11 Eventide Asset Management, LLC 0.22% 507,000 $16.3M
12 Baker BROS. Advisors LP 0.16% 996,351 $32.1M
13 Mirador Capital Partners LP 0.16% 40,124 $1.3M
14 Virtus Investment Advisers, LLC 0.11% 14,920 $481K
15 a16z Capital Management, L.L.C. 0.09% 415,000 $13.4M
16 Sofinnova Investments, Inc. 0.05% 32,436 $1.0M
17 Soros Fund Management LLC 0.04% 100,000 $3.2M
18 Readystate Asset Management LP 0.03% 30,000 $967K
19 Seven Grand Managers, LLC 0.03% 25,000 $806K
20 Axq Capital, LP 0.02% 7,020 $226K
21 Alyeska Investment Group, L.P. 0.02% 290,000 $9.3M
22 Polen Capital Management LLC 0.02% 63,514 $2.0M
23 Jupiter Topco LLC 0.02% 1,314,267 $42.4M
24 Ghisallo Capital Management LLC 0.02% 25,000 $806K
25 Lanark Financial, INC. 0.01% 5,358 $173K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Aktis Oncology Inc Com (AKTS)

What does the Smart Money Trend signal show for AKTS?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added AKTS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for AKTS?

More buyers than sellers — 77% buying: Last quarter: 81 funds were net buyers (54 opened a brand new position + 27 added to an existing one). Only 24 were sellers (16 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for AKTS holders?

Strong quality — 22% AUM from major funds: 30 of 113 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held AKTS?

Mostly new holders — 100% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →